Spatial Transcriptomics Is Changing How We Do Biology: Fei Chen, The Broad Institute

About this episode

Fei Chen discusses how spatial transcriptomics is revolutionizing biology by integrating gene expression with cellular structure.

Fei Chen of the Broad Institute describes the original problem simply: genomics gave us powerful inventories of gene expression, while microscopy gave us structure—yet the two lived in separate worlds. “You could either have your structure or you could have gene expression, but you couldn’t have both.” In this conversation, Fei walks us through how Slide-tags—now commercialized as Takara Bio Trekker technology—set out to close that gap. Instead of mapping gene expression onto a grid, his team flipped the problem: barcoding the cells in place, then reading them out with single-cell sequencing. The result is something closer to a GPS system for cells. What this unlocks is not just better maps, but better biology. Better questions. In cancer, Fei describes the discovery of local immune “circuits” that determine whether tumors respond to immunotherapy. And more broadly, spatial data turns tissue itself into a kind of experiment itself. Is this the biology of the future? “The spatial context is a natural experiment that has happened.” Chapters: 0:00 The problem: structure vs gene expression1:36 A GPS for cells8:59 Immune circuits and cancer response20:04 Tissue as experiment26:24 New…

People in this episode

Host: Theral Timpson

Guest: Fei Chen

Topics covered

• spatial transcriptomics
• gene expression
• cancer immunotherapy
• single-cell sequencing
• spatial biology

Keywords

• spatial transcriptomics
• gene expression
• cancer
• immunotherapy
• single-cell sequencing
• spatial biology
• cellular structure

Mentioned in this episode

Organizations: The Broad Institute

Products: Takara Bio Trekker technology

More episodes of Mendelspod Podcast

• Gary Schroth on Connecting Cellular Behavior to the Transcriptome · June 11, 2026 · 33 min
• Two-Thirds of High-Risk Breast Cancer Patients May Avoid Chemotherapy According to Veracyte Data Presented at ASCO · June 9, 2026 · 27 min
• Building the Diagnostic Layer of Modern Cancer Care with Rita Shaknovich and Karina Kulangara of Agilent · May 29, 2026 · 32 min
• Mapping the Multi-Omic Era with Eric Green of Illumina · May 28, 2026 · 44 min
• Inside Proteomics at Thermo Fisher with Yan Zhang · May 21, 2026 · 5 min
• Separating Epigenetic Signals Improves Early Cancer Detection with Rob Osborne, Biomodal · May 19, 2026 · 23 min